US Stock MarketDetailed Quotes

APLT Applied Therapeutics

Watchlist

9.625
+0.355+3.83%

Close Nov 22 16:00 ET

1.12BMarket Cap-6778P/E (TTM)

Applied Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Applied Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 2 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual

Estimate

Date	Period	Revenue/Estimate	Earnings Call
--	2025/Q1	-- / 19.150M	--
--	2024/Q4	-- / 183.330K	--
--	2024/Q3	122.000K / 0.000	--
--	2024/Q2	144.000K / 2.500M	--
--	2024/Q1	190.000K / 2.500M	--

DatePeriodRevenue/EstimateEarnings Call

--2025/Q1-- / 19.150M--

--2024/Q4-- / 183.330K--

--2024/Q3122.000K / 0.000--

--2024/Q2144.000K / 2.500M--

--2024/Q1190.000K / 2.500M--

Unlock Free Earnings Estimates

Open Account

Applied Therapeutics Earnings Reports

Applied Therapeutics | 10-Q: Q3 2024 Earnings Report

Nov 7 07:33 ET

Applied Therapeutics | 8-K: Applied Therapeutics Reports Third Quarter 2024 Financial Results

Nov 7 07:23 ET

Applied Therapeutics | 10-Q: Q2 2024 Earnings Report

Aug 7 07:16 ET

Applied Therapeutics | 8-K: Applied Therapeutics Reports Second Quarter 2024 Financial Results

Aug 7 07:11 ET

Analyst Rating

Updated: Nov 8, 2024

Strong Buy

Buy
100.00%
Hold
0.00%
Sell
0.00%

Price Target

No Data

Heat List

Overall